2021
DOI: 10.1080/09537104.2021.1967917
|View full text |Cite
|
Sign up to set email alerts
|

Frozen and cold-stored platelets: reconsidered platelet products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(23 citation statements)
references
References 92 publications
0
23
0
Order By: Relevance
“…Patients requiring massive transfusion make up for the minority of total blood products demand in most civilian hospitals, particularly in developed countries, as many other transfusion indications like non-acute controlled hemorrhage, sickle cell disease, homozygous beta thalassemia, symptomatic anemia, and myelodysplastic syndrome usually require one type of component. Also, in the future WB may become less important when new developments that improve shelf life and logistics (i.e., dried plasma and cold stored PLT), and thus the early availability of these components beside RBCs in the (pre)-hospital setting 78,79 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Patients requiring massive transfusion make up for the minority of total blood products demand in most civilian hospitals, particularly in developed countries, as many other transfusion indications like non-acute controlled hemorrhage, sickle cell disease, homozygous beta thalassemia, symptomatic anemia, and myelodysplastic syndrome usually require one type of component. Also, in the future WB may become less important when new developments that improve shelf life and logistics (i.e., dried plasma and cold stored PLT), and thus the early availability of these components beside RBCs in the (pre)-hospital setting 78,79 …”
Section: Discussionmentioning
confidence: 99%
“…Also, in the future WB may become less important when new developments that improve shelf life and logistics (i.e., dried plasma and cold stored PLT), and thus the early availability of these components beside RBCs in the (pre)-hospital setting. 78,79…”
Section: Discussionmentioning
confidence: 99%
“…The standard technical procedure for the conservation of platelets from PRP includes gentle agitation in proper aseptic containers at room temperature of 20-24 °C [ 5 , 6 ]. Under these conditions, storage is limited to 5 days since bacterial growth is favored [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Introducing this PI step in PCs production, enables to increase the storage duration from 5 to 7 days at 22°C. However, the PI process, 1–8 storage conditions, and duration 9–13 modify platelet functions 14 …”
Section: Introductionmentioning
confidence: 99%
“…Introducing this PI step in PCs production, enables to increase the storage duration from 5 to 7 days at 22°C. However, the PI process, [1][2][3][4][5][6][7][8] storage conditions, and duration [9][10][11][12][13] modify platelet functions. 14 Understanding the in vivo impact of transfused platelets on patients is then primordial.…”
Section: Introductionmentioning
confidence: 99%